Allspring Global Investments Holdings, LLC Tango Therapeutics, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$2.93 - $11.26 $23,900 - $91,847	8,157 New	8,157 $91,000
Q2 2023 Jul 18, 2023	BUY	$2.67 - $4.7 $38,640 - $68,018	14,472 New	14,472 $48,000
Q4 2022 Jan 23, 2023	SELL	$3.41 - $8.29 $144,082 - $350,277	-42,253 Reduced 59.53%	28,730 $208 Million
Q3 2022 Oct 26, 2022	BUY	$3.25 - $5.46 $230,694 - $387,567	70,983 New	70,983 $256,000

Others Institutions Holding TNGX

# of Institutions

123

Shares Held

91.7M

Call Options Held

3.1K

Put Options Held

1.5K

Trv Gp Iv, LLC Boston, MA

16.9M
Shares

$52.6 Million
80.09% of portfolio
Eco R1 Capital, LLC San Francisco, CA

13.3M
Shares

$41.6 Million
4.45% of portfolio
Boxer Capital, LLC San Diego, CA

8.2M
Shares

$25.6 Million
3.35% of portfolio
Nextech Invest Ag

5.53M
Shares

$17.3 Million
6.95% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.02M
Shares

$15.7 Million
0.02% of portfolio

View Full List

About Tango Therapeutics, Inc.

Ticker TNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,067,296
Market Cap $275M
Description
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...

More about TNGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account